Skip to Main Content

Paper Details

Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials.
Human Vaccines and Immunotherapeutics
18
2019
HZ, RZV, coronary heart disease, herpes zoster, medical conditions, participant, participants
Author NameAffiliation
Myron J LevinUniversity of Colorado
  • 1 - 1

Datasets

Release 1.2